In this Webinar, you’ll learn from underwriting leaders at Swiss Re, SCOR, Ethos and Sikka about:
With the need for increased speed in underwriting, often in the absence of a paramed exam, Sikka’s indicator suite “meets the moment” for a post-pandemic world.
Sikka is a very interesting company that’s developed sophisticated indicators around Tobacco, Cardiovascular and Diabetes from dental records.”— Manisha Dias, FSA, FCIA, CERA – AVP of Strategic Partnerships at SCOR
SANTA CLARA, CA, USA, June 16, 2021 — Sikka.ai, the most widely used API integration platform for dental practices in the U.S. and Canada, announces the launch of Sikka Insights, a new business unit that leverages consent-based oral care data to facilitate life insurance underwriting that is both faster and more accurate. This is accomplished through the use of Sikka Insights’ groundbreaking tobacco, diabetes, cardiovascular disease, cancer and marijuana usage indicators, which enable more accurate applicant risk classification by carriers and re-insurers, whether used separately or in conjunction with one another.
COVID-19 seems to have created a “wake up” moment, raising awareness of the need to protect loved ones if something was to happen.
We are living through extraordinary times, the first truly worldwide pandemic in our lifetimes, which has effectively halted economies and introduced the concepts of #socialdistancing and #flatteningthecurve into the vernacular (not to mention #PPE). Beyond the horrific infection rate and loss of life, coronavirus’ impact on travel, retail, hospitality and other industries has been so profound that it may take years to recover. However, it has had at least one positive impact — the pandemic has forced people to confront their mortality in a way that larger threats (heart disease, car accidents, diabetes) haven’t over the last 10 years.